002210.KS · 동성제약

South Korea · RS rating 79 · As of 2026-10-14

Price1,241.00 KRW
1-day change+3.1%
RS rating (overall / 1M / 3M / 12M)79 / 11 / 83 / 80
StageAdvancing
Composite / Minervini / CANSLIM score32 / 44 / 25
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-11350.0%
Sales growth Q/Q+15.5%
Distance from 52-week high+36.2%
Market cap (USD)$90.0M
Open South Korea in the interactive screener